Skip to main content

ExodusPoint Capital Management, LP

Position in FLGT — Fulgent Genetics, Inc.

CIK 1736225 NEW YORK, NY

Position in FLGT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$966,225
+$599,102 QoQ
Shares Held
47,087
+236.9% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#51
of 142 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FLGT Over Time

Shares Held

Position Value (USD)

Derivatives in FLGT

reported options exposure · as of Dec 31, 2020
CallValue
$1,042,000
CallShares
20,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $101,462,417 across 18 Diagnostics & Research names. FLGT ranks #13 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FLGT

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $966,225 47,087
2025-12-31 $367,123 13,975
2025-06-30 $765,260 38,494
2024-12-31 $1,702,878 92,197
2024-09-30 $1,142,541 52,579
2024-06-30 $1,820,363 92,781
2023-12-31 $580,483 20,079
2023-09-30 $591,060 22,104
2023-06-30 $813,512 21,969
2023-03-31 $2,617,078 83,827
2022-09-30 $507,110 13,303
2022-06-30 $1,292,633 23,705
2022-03-31 $460,086 7,372
2021-12-31 $330,538 3,286
2020-12-31 $1,042,000 20,000
2020-09-30 $1,933,932 48,300
2020-03-31 $362,913 33,728